American pharmaceutical giant Cosette has terminated its $672 million takeover bid for Adelaide-headquartered drug company Mayne Pharma, but the target company says it will challenge the move in the courts.

Mayne shares fell as much as 7 per cent on Wednesday after it told investors it had received notice from Cosette that it would terminate the $7.40 per share offer, setting the stage for a potential legal battle.